User profiles for Hanna Rennert

Hanna Rennert

Director, Molecular Pathology Lab, Weill Cornell Medicine
Verified email at med.cornell.edu
Cited by 4354

Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions

…, C Chiu, RE Schwartz, N Tatonetti, H Rennert… - Nature …, 2021 - nature.com
In less than nine months, the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
killed over a million people, including >25,000 in New York City (NYC) alone. The …

Whole-exome sequencing of metastatic cancer and biomarkers of treatment response

…, A Sigaras, A Romanel, H Rennert… - JAMA …, 2015 - jamanetwork.com
Importance Understanding molecular mechanisms of response and resistance to anticancer
therapies requires prospective patient follow-up and clinical and functional validation of …

Genetic risk assessment in carrier testing for spinal muscular atrophy

S Ogino, DGB Leonard, H Rennert… - American journal of …, 2002 - Wiley Online Library
As evidenced by the complete absence of a functionally critical sequence in exon 7,
approximately 94% of individuals with clinically typical spinal muscular atrophy (SMA) lack both …

[PDF][PDF] Early introductions and transmission of SARS-CoV-2 variant B. 1.1. 7 in the United States

…, SM Morrison, S Murphy, C Neal, E Laszlo, H Rennert… - Cell, 2021 - cell.com
The emergence and spread of SARS-CoV-2 lineage B.1.1.7, first detected in the United
Kingdom, has become a global public health concern because of its increased transmissibility. …

Clinical, pathologic, and molecular features of early-onset colorectal carcinoma

…, M Goodarzi, XK Zhou, H Rennert… - The American journal …, 2009 - journals.lww.com
The incidence of colorectal carcinoma has increased among patients< 40 years of age for
unclear reasons. In this study, we describe the clinical, pathologic, and molecular features of …

Neoadjuvant therapy induces loss of MSH6 expression in colorectal carcinoma

F Bao, NC Panarelli, H Rennert, DL Sherr… - The American journal …, 2010 - journals.lww.com
Immunohistochemical stains are routinely used to detect abnormal DNA mismatch repair (MMR)
protein expression in colorectal carcinomas, particularly when Lynch syndrome is …

Clinical performance of SARS-CoV-2 molecular tests

…, LF Westblade, S Whittier, H Rennert… - Journal of clinical …, 2020 - Am Soc Microbiol
Molecular testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the
gold standard for diagnosis of coronavirus disease 2019 (COVID-19), but the clinical …

Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer …

H Rennert, K Eng, T Zhang, A Tan, J Xiang… - NPJ genomic …, 2016 - nature.com
We describe Exome Cancer Test v1. 0 (EXaCT-1), the first New York State-Department of
Health-approved whole-exome sequencing (WES)-based test for precision cancer care. EXaCT…

Urine microRNA as potential biomarkers of autosomal dominant polycystic kidney disease progression: description of miRNA profiles at baseline

IZ Ben-Dov, YC Tan, P Morozov, PD Wilson, H Rennert… - PloS one, 2014 - journals.plos.org
Background Autosomal dominant polycystic kidney disease (ADPKD) is clinically heterogenic.
Biomarkers are needed to predict prognosis and guide management. We aimed to profile …

The cancer precision medicine knowledge base for structured clinical-grade mutations and interpretations

…, H Zia, P Tavassoli, H Rennert… - Journal of the …, 2017 - academic.oup.com
Objective: This paper describes the Precision Medicine Knowledge Base (PMKB; https://pmkb.weill.cornell.edu
), an interactive online application for collaborative editing, maintenance, …